Finnish research group discovers a new immune system regulator
Regulatory T cells are critical controllers of the immune response. The majority of T cells boost the immune response enhancing the ability to destroy cancer cells, viruses and bacteria.
In contrast, regulatory T cells can sometimes suppress the immune system's ability to attack cancer cells, allowing cancer to grow and spread.
In these instances, inhibiting or braking the regulatory T cell activity would be needed.
-We discovered that a protein called 'Hypermethylated In Cancer 1', or HIC1, serves as the key regulator of regulatory T cells controlling the expression of a large set of genes contributing to T cell function, says Academy Professor Riitta Lahesmaa.
– In addition, with genome-wide methods we show that HIC1 binds to sites in the nucleus that often contain genetic variations associated with immune-mediated diseases. This gives us completely new insights into molecular mechanisms that regulate T cell function and immune response in general, continues Lahesmaa.
The study was published in the Cell Reports journal on 20 February 2018.
Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells, available online: http://www.
All news from this category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
New EU project on effects of micro- and nanoplastics in agriculture
The University of Bayreuth is a partner in the new European “PAPILLONS” consortium for micro- and nanoplastics research in agriculture. 20 universities and research institutions from 12 countries will jointly…